Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 194 SEK -1.02% Market Closed
Market Cap: kr52.8B

EV/EBITDA

8.7
Current
6%
Cheaper
vs 3-y average of 9.2

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
8.7
=
Enterprise Value
kr57.6B
/
EBITDA
kr6.7B

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
8.7
=
Enterprise Value
kr57.6B
/
EBITDA
kr6.7B

Valuation Scenarios

Getinge AB is trading below its 3-year average

If EV/EBITDA returns to its 3-Year Average (9.2), the stock would be worth kr206.12 (6% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+71%
Average Upside
24%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 8.7 kr194
0%
3-Year Average 9.2 kr206.12
+6%
5-Year Average 9.6 kr214.95
+11%
Industry Average 9.2 kr205.83
+6%
Country Average 14.9 kr332.14
+71%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
kr57.6B
/
Jan 2026
kr6.7B
=
8.7
Current
kr57.6B
/
Dec 2026
kr6.9B
=
8.3
Forward
kr57.6B
/
Dec 2027
kr7.5B
=
7.6
Forward
kr57.6B
/
Dec 2028
kr8.1B
=
7.1
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
SE
Getinge AB
STO:GETI B
52.8B SEK 8.7 23.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
170B USD 45.1 59.5
US
Abbott Laboratories
NYSE:ABT
160.6B USD 14 25.6
US
Stryker Corp
NYSE:SYK
126.1B USD 19.9 38.8
IE
Medtronic PLC
NYSE:MDT
107.5B USD 12.9 23.3
US
Boston Scientific Corp
NYSE:BSX
97.4B USD 19.9 33.6
DE
Siemens Healthineers AG
XETRA:SHL
40.6B EUR 10.8 19.2
US
Edwards Lifesciences Corp
NYSE:EW
46.3B USD 23.4 43.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.7B USD 29.9 42.2
US
Becton Dickinson and Co
NYSE:BDX
44.1B USD 10 25.1
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
31.9B USD 11.1 15.3

Market Distribution

Lower than 76% of companies in Sweden
Percentile
24rd
Based on 1 230 companies
24rd percentile
8.7
Low
0.2 — 9.4
Typical Range
9.4 — 19.4
High
19.4 —
Distribution Statistics
Sweden
Min 0.2
30th Percentile 9.4
Median 14.9
70th Percentile 19.4
Max 4 325.3

Getinge AB
Glance View

Market Cap
52.8B SEK
Industry
Health Care

Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.

GETI B Intrinsic Value
226.37 SEK
Undervaluation 14%
Intrinsic Value
Price kr194
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett